Premium
This is an archive article published on December 27, 2023

Epilepsy drug supplied to Delhi government hospitals ‘not of standard quality’: report

Samples were collected from three major hospitals—IHBAS (Institute of Human Behaviour and Allied Sciences), Lok Nayak Hospital and Deen Dayal Upadhyay Hospital.

epilepsy drugThe samples of sodium valproate, critical for managing epilepsy and seizures, were found spurious during the ongoing examination of drugs undertaken. (Representative Photo/File)

Samples of an epilepsy drug collected from a Delhi government facility have been found spurious in a test conducted at a government laboratory, sources said Wednesday.

The samples of sodium valproate, critical for managing epilepsy and seizures, were found spurious during the ongoing examination of drugs undertaken after Lieutenant Governor VK Saxena recommended a CBI inquiry into the alleged supply of non-standard drugs—including some live-saving medicines—to Delhi government hospitals and the AAP’s flagship Mohalla Clinics.

According to sources, the epilepsy drug samples were found to have failed the tests at the Regional Drug Testing Laboratory (RDTL), Chandigarh. A series of medicines being provided to patients at hospitals under the Delhi government and Mohalla Clinics were “not meeting the standards”, they added.

“Sodium Valproate was found to be not meeting the standards…The drug is being supplied in Delhi government hospitals and was found to be of ‘not of standard quality’ in a report issued by the government analyst, that is the RDTL, on 22nd December 2023,” a source said.

According to the sources, the test report stated that the sample was “not of standard quality as defined in the Drugs and Cosmetics Act, 1940…” as it did not conform to the “claim as per IP 2022 in respect to the Dissolution of Sodium Valproate.” “In the dissolution test, out of 24 units seven units were found less than Q-15 and one unit was found less than Q-25, as per IP 2022 the limit of Q is NLT 75%…,” according to the report.

Hitting back after Saxena’s allegations last week, Health Minister Saurabh Bharadwaj sought the suspension of the health secretary and other officials, claiming that no action was taken on his direction to conduct an audit of the medicines procured.

Raising the issue in a note to Chief Secretary Naresh Kumar, Saxena had attached a Directorate of Vigilance report on the matter.

Story continues below this ad

Following complaints of “substandard medicines” being supplied to Delhi government hospitals, the drugs controller under the health department had sent samples for testing. The lab reports were then sent to the vigilance department for necessary action.

According to officials, samples were collected from three major hospitals—IHBAS (Institute of Human Behaviour and Allied Sciences), Lok Nayak Hospital and Deen Dayal Upadhyay Hospital.

The allegedly spurious drugs include cephalexin, a life-saving antibiotic for the treatment of lung and urinary tract infections; dexamethasone, a steroid for curing life-threatening inflammation in lungs, joints and swelling in the body; levetiracetam, an anti-epilepsy and anti-anxiety psychiatric drug; and amlodipine for hypertension.

The Vigilance report, reviewed by The Indian Express, says the lab reports found that over 10 per cent of the samples were found to be “not of standard quality”. Of the 43 samples that were sent to government labs, three samples failed the test while reports on 12 samples are pending. Of another 43 samples sent to private labs, five failed the test.

Story continues below this ad

The vigilance department recommended that since over 10 per cent samples had failed, distribution of such medicines should be stopped immediately and the scope of sampling should be increased. It also sought to investigate the role of suppliers under the health department, other than the Central Procurement Agency, that had procured the drugs.

Addressing a press conference, Bharadwaj had asked why the central government was not taking action against Health Secretary SB Deepak, who he said was responsible for drug procurement.

“I have issued several directions about the audit of these drugs but no action-taken report has been submitted by the officials… The Centre has ended the accountability of officials to the health minister, so what more can we do? The officials do not listen to our orders at the meetings,” Bharadwaj said.

On Wednesday, the Delhi BJP held a protest near the AAP headquarters over the issue. Addressing protesters, Delhi BJP president Virendra Sachdeva said, “Today, another sample report has arrived and that was also found to be fake. The tender for the medicines whose samples were found to be fake had ended.”

Story continues below this ad

The AAP, in turn, accused the BJP of “spreading blatant lies” on the matter by calling the said drug sample spurious. “Basically, the test report being shared by BJP says it has got all genuine ingredients (salt formulation). The only thing which is not standard is the dissolution of this drug. This in layman terms means a standard drug may dissolve in 30 seconds in the body while this sample may take 40 seconds,” it stated.

Jatin Anand is an Assistant Editor with the national political bureau of The Indian Express. With over 16 years of experience in mainstream journalism, he is a seasoned expert in national governance, electoral politics, and bureaucratic affairs. Having covered high-stakes beats including the Election Commission of India (ECI), intelligence, and urban development, Jatin provides authoritative analysis of the forces shaping Indian democracy. He is an alumnus of Zakir Husain Delhi College (DU) and the prestigious Asian College of Journalism (ACJ), Chennai, where he specialized in Print Journalism. Expertise High-Stakes Beat Coverage: Throughout his decade-and-a-half career, Jatin has covered some of the most sensitive and influential beats in the country, including: The Election Commission of India (ECI): Monitoring electoral policy, reforms, and the conduct of national and state polls. National Security & Intelligence: Reporting on the internal mechanisms and developments within India's security apparatus. Urban Development: Analyzing the policies and bureaucratic processes driving the transformation of India’s cities. National Political Bureau: In his current role, he tracks the intersection of policy and politics, offering deep-dive reporting on the Union government and national political movements. Academic Credentials: Zakir Husain Delhi College (DU): Alumnus of one of Delhi's premier institutions. Asian College of Journalism (ACJ), Chennai: Specialized in Print Journalism at India's most prestigious journalism school. ... Read More

Stay updated with the latest - Click here to follow us on Instagram

Advertisement
Loading Recommendations...
Advertisement
Latest Comment
Post Comment
Read Comments